The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Passage of inhaled particles into the blood circulation in humans
Nemmar, A., Hoet, P. H. M., Vanquickenborne, B., Dinsdale, D., Thomeer, M., Hoylaerts, M. F., Vanbilloen, H., Mortelmans, L., & Nemery, B. (2002) · Circulation · doi:10.1161/hc0402.104118 · Cited by 1,719
Eder, W., Ege, M. J., & von Mutius, E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054308 · Cited by 1,621
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
VALAVANIDIS, A., FIOTAKIS, K., & VLACHOGIANNI, T. (2008) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590500802494538 · Cited by 1,491
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Self-citationIncreased Particulate Air Pollution and the Triggering of Myocardial Infarction
Peters, A., Dockery, D. W., Muller, J. E., & Mittleman, M. A. (2001) · Circulation · doi:10.1161/01.cir.103.23.2810 · Cited by 1,471
Geiser, M., Rothen-Rutishauser, B., Kapp, N., Schürch, S., Kreyling, W., Schulz, H., Semmler, M., Hof, V. I., Heyder, J., & Gehr, P. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8006 · Cited by 1,407
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Mehnert, W., & Mäder, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.021 · Cited by 981
Jemal, A., Thun, M. J., Ries, L. A. G., Howe, H. L., Weir, H. K., Center, M. M., Ward, E., Wu, X.-C., Eheman, C., Anderson, R., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn389 · Cited by 957
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Lunts, A., Kreyling, W., & Cox, C. (2002) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/00984100290071658 · Cited by 846
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Formulation strategy and use of excipients in pulmonary drug delivery
Pilcer, G., & Amighi, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.017 · Cited by 791
Kreyling, W. G., Semmler, M., Erbe, F., Mayer, P., Takenaka, S., Schulz, H., Oberdörster, G., & Ziesenis, A. (2002) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/00984100290071649 · Cited by 790
Ultrafine (nanometre) particle mediated lung injury
Donaldson, K., Li, X. Y., & MacNee, W. (1998) · Journal of Aerosol Science · doi:10.1016/s0021-8502(97)00464-3 · Cited by 770
Deposition and biokinetics of inhaled nanoparticles
Geiser, M., & Kreyling, W. G. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-2 · Cited by 747
Foster, K. A., Oster, C. G., Mayer, M. M., Avery, M. L., & Audus, K. L. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4172 · Cited by 713
van EEDEN, S. F., TAN, W. C., SUWA, T., MUKAE, H., TERASHIMA, T., FUJII, T., QUI, D., VINCENT, R., & HOGG, J. C. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2010160 · Cited by 698
Inhaled nanoparticles—A current review
Yang, W., Peters, J. I., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.02.011 · Cited by 666
The normal human lung: ultrastructure and morphometric estimation of diffusion capacity
Gehr, P., Bachofen, M., & Weibel, E. R. (1978) · Respiration Physiology · doi:10.1016/0034-5687(78)90104-4 · Cited by 650
Warheit, D. B., Webb, T. R., Reed, K. L., Frerichs, S., & Sayes, C. M. (2007) · Toxicology · doi:10.1016/j.tox.2006.11.002 · Cited by 644
Nanoparticles for drug delivery to the lungs
Sung, J. C., Pulliam, B. L., & Edwards, D. A. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.09.005 · Cited by 643
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Ambient particle inhalation and the cardiovascular system: potential mechanisms.
Donaldson, K., Stone, V, Seaton, A., & MacNee, W. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109s4523 · Cited by 634
Regional Lung Deposition and Bronchodilator Response as a Function of β 2 -Agonist Particle Size
Usmani, O. S., Biddiscombe, M. F., & Barnes, P. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1414oc · Cited by 578
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
The Lungs as a Portal of Entry for Systemic Drug Delivery
Patton, J. S., Fishburn, C. S., & Weers, J. G. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-049ta · Cited by 563
Deposition, retention, and clearance of inhaled particles.
Lippmann, M., Yeates, D. B., & Albert, R. E. (1980) · Occupational and Environmental Medicine · doi:10.1136/oem.37.4.337 · Cited by 557
Lipka, J., Semmler-Behnke, M., Sperling, R. A., Wenk, A., Takenaka, S., Schleh, C., Kissel, T., Parak, W. J., & Kreyling, W. G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.009 · Cited by 529
Gojova, A., Guo, B., Kota, R. S., Rutledge, J. C., Kennedy, I. M., & Barakat, A. I. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.8497 · Cited by 511
Solid lipid nanoparticles for targeted brain drug delivery.
BLASI, P., GIOVAGNOLI, S., SCHOUBBEN, A., RICCI, M., & ROSSI, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.011 · Cited by 506
Aerosol drug delivery: developments in device design and clinical use
Dolovich, M. B., & Dhand, R. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60926-9 · Cited by 505
Possible mechanisms to explain dust overloading of the lungs
MORROW, P. (1988) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(88)90284-9 · Cited by 500
Donaldson, K., Stone, V, Clouter, A., Renwick, L., & MacNee, W. (2001) · Occupational and Environmental Medicine · doi:10.1136/oem.58.3.211 · Cited by 499
SiO2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells
Yang, X., Liu, J., He, H., Zhou, L., Gong, C., Wang, X., Yang, L., Yuan, J., Huang, H., He, L., et al. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-1 · Cited by 473
Correlation between particle size, in vivo particle persistence, and lung injury
Oberdörster, G., Ferin, J., & Lehnert, B. E. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s5173 · Cited by 466
Targeted delivery of nanoparticles for the treatment of lung diseases
Azarmi, S., Roa, W. H., & Löbenberg, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.006 · Cited by 440
Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration
Jacobs, C., & Müller, R. H. (2002) · Pharmaceutical Research · doi:10.1023/a:1014276917363 · Cited by 439
C. L. Tran, D. B. (2000) · Inhalation Toxicology · doi:10.1080/08958370050166796 · Cited by 436
Lipid nanoparticles for parenteral delivery of actives
Joshi, M. D., & Müller, R. H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.003 · Cited by 433
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
Bunjes, H., Westesen, K., & Koch, M. H. J. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04286-5 · Cited by 425
Current hypotheses on the mechanisms of toxicity of ultrafine particles.
Donaldson, K., & Stone, V. (2003) · PubMed · Cited by 425
The lung as a route for systemic delivery of therapeutic proteins and peptides
Uchenna Agu, R., Ikechukwu Ugwoke, M., Armand, M., Kinget, R., & Verbeke, N. (2001) · Respiratory Research · doi:10.1186/rr58 · Cited by 411
Kreyling, W. G., Semmler-Behnke, M., Seitz, J., Scymczak, W., Wenk, A., Mayer, P., Takenaka, S., & Oberdörster, G. (2009) · Inhalation Toxicology · doi:10.1080/08958370902942517 · Cited by 384
SINGH, S., SHI, T., DUFFIN, R., ALBRECHT, C., VANBERLO, D., HOHR, D., FUBINI, B., MARTRA, G., FENOGLIO, I., & BORM, P. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.05.001 · Cited by 359
Hussain, S., Boland, S., Baeza-Squiban, A., Hamel, R., Thomassen, L. C. J., Martens, J. A., Billon-Galland, M. A., Fleury-Feith, J., Moisan, F., Pairon, J.-C., et al. (2009) · Toxicology · doi:10.1016/j.tox.2009.04.001 · Cited by 347
The Impact of COPD on Lung Health Worldwide
Hurd, S. (2000) · Chest · doi:10.1378/chest.117.2_suppl.1s · Cited by 340
Hsiao, I.-L., & Huang, Y.-J. (2011) · Science of The Total Environment · doi:10.1016/j.scitotenv.2010.12.033 · Cited by 335
Impairment of Alveolar Macrophage Phagocytosis by Ultrafine Particles
Renwick, L. C., Donaldson, K., & Clouter, A. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9128 · Cited by 320
Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318
Paur, H.-R., Cassee, F. R., Teeguarden, J., Fissan, H., Diabate, S., Aufderheide, M., Kreyling, W. G., Hänninen, O., Kasper, G., Riediker, M., et al. (2011) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2011.06.005 · Cited by 316
Becker, S., Soukup, J. M., Gilmour, M. I., & Devlin, R. B. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0330 · Cited by 312
Lung Particle Overload: Implications for Occupational Exposures to Particles
Oberdorster, G. (1995) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1995.1017 · Cited by 310
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Dry powder inhalers (DPIs)—A review of device reliability and innovation
Islam, N., & Gladki, E. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.044 · Cited by 298
Schubert, M. A., & Müller-Goymann, C. C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.006 · Cited by 297
Warheit, D. B., Sayes, C. M., Reed, K. L., & Swain, K. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.07.001 · Cited by 297
Warheit, D. B., Webb, T. R., Colvin, V. L., Reed, K. L., & Sayes, C. M. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl128 · Cited by 297
Acute pulmonary effects of ultrafine particles in rats and mice.
Oberdörster, G., Finkelstein, J. N., Johnston, C. J., Gelein, R. M., Cox, C., Baggs, R. B., & Elder, A. C. P. (2000) · PubMed · Cited by 287
Wittmaack, K. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9254 · Cited by 280
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
Cavalli, R. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04822-3 · Cited by 273
Al-Qadi, S., Grenha, A., Carrión-Recio, D., Seijo, B., & Remuñán-López, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.008 · Cited by 265
Curcuminoids-loaded lipid nanoparticles: Novel approach towards malaria treatment
Nayak, A. P., Tiyaboonchai, W., Patankar, S., Madhusudhan, B., & Souto, E. B. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2010.07.020 · Cited by 259
Driscoll, K. (1997) · Carcinogenesis · doi:10.1093/carcin/18.2.423 · Cited by 256
Travis, W. D., Lubin, J., Ries, L., & Devesa, S. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960615)77:12<2464::aid-cncr8>3.0.co;2-m · Cited by 254
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
Cai, S., Yang, Q., Bagby, T. R., & Forrest, M. L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.017 · Cited by 252
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
Solid lipid nanoparticles for pulmonary delivery of insulin
Liu, J., Gong, T., Fu, H., Wang, C., Wang, X., Chen, Q., Zhang, Q., He, Q., & Zhang, Z. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.008 · Cited by 248
Alveolar clearance and the role of the pulmonary lymphatics.
Lauweryns, J. M., & Baert, J. H. (1977) · PubMed · doi:10.1164/arrd.1977.115.4.625 · Cited by 233
CHATTOPADHYAY, P., SHEKUNOV, B., YIM, D., CIPOLLA, D., BOYD, B., & FARR, S. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.010 · Cited by 227
Lymphatic targeting with nanoparticulate system
Nishioka, Y., & Yoshino, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00121-6 · Cited by 223
Drug Delivery via the Respiratory Tract
BYRON, P. R., & PATTON, J. S. (1994) · Journal of Aerosol Medicine · doi:10.1089/jam.1994.7.49 · Cited by 218
Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H. P., Plank, H., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.040 · Cited by 216
Self-citationLymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000054933 · Cited by 213
Harivardhan Reddy, L., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. S. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.028 · Cited by 212
Enzymatic degradation of SLN—effect of surfactant and surfactant mixtures
Olbrich, C., & Müller, R. H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00404-9 · Cited by 208
Warheit, D. B. (2004) · Materials Today · doi:10.1016/s1369-7021(04)00081-1 · Cited by 200
Bioadhesive drug delivery systems
Duchêne, D. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90106-n · Cited by 199
Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract
Ponchel, G., Montisci, M.-J., Dembri, A., Durrer, C., & Duchêne, D. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00098-2 · Cited by 191
Choosing inhaler devices for people with asthma: Current knowledge and outstanding research needs
Haughney, J., Price, D., Barnes, N. C., Virchow, J. C., Roche, N., & Chrystyn, H. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.04.012 · Cited by 190
Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects
Möller, W., Häußinger, K., Winkler-Heil, R., Stahlhofen, W., Meyer, T., Hofmann, W., & Heyder, J. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00970.2003 · Cited by 189
Dosimetry and toxicology of inhaled ultrafine particles
Schmid, O., Möller, W., Semmler-Behnke, M., A. Ferron, G., Karg, E., Lipka, J., Schulz, H., Kreyling, W. G., & Stoeger, T. (2009) · Biomarkers · doi:10.1080/13547500902965617 · Cited by 186
Hawley, A. E., Davis, S. S., & Illum, L. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00045-9 · Cited by 183
Airway Epithelial Cells, Cytokines, and Pollutants
MILLS, P. R., DAVIES, R. J., & DEVALIA, J. L. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.supplement_1.11 · Cited by 179
Nassimi, M., Schleh, C., Lauenstein, H. D., Hussein, R., Hoymann, H. G., Koch, W., Pohlmann, G., Krug, N., Sewald, K., Rittinghausen, S., et al. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.014 · Cited by 173
Invited Review: Development of Fat Emulsions
WRETLIND, A. (1981) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607181005003230 · Cited by 172
Glucocorticoid receptor localization in normal and asthmatic lung.
Adcock, I. M., Gilbey, T., Gelder, C. M., Chung, K. F., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810618 · Cited by 171
Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles
Beck-Speier, I., Dayal, N., Karg, E., Maier, K. L., Schumann, G., Schulz, H., Semmler, M., Takenaka, S., Stettmaier, K., Bors, W., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.01.004 · Cited by 167
Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation
Sadauskas, E., Jacobsen, N. R., Danscher, G., Stoltenberg, M., Vogel, U., Larsen, A., Kreyling, W., & Wallin, H. (2009) · Chemistry Central Journal · doi:10.1186/1752-153x-3-16 · Cited by 160
Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma
Capstick, T., & Clifton, I. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.89 · Cited by 158
Tronde, A., Nordén, B. O., Marchner, H., Wendel, A., Lennernäs, H., & Bengtsson, U. H. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10386 · Cited by 158
In vivo animal models for drug delivery across the lung mucosal barrier☆
Cryan, S., Sivadas, N., & Garcia‐Contreras, L. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.023 · Cited by 156
Biodegradation of solid lipid nanoparticles as a function of lipase incubation time
Müller, R. H., Rühl, D., & Runge, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04731-x · Cited by 155
Schöler, N., Hahn, H. H., Müller, R. H., & Liesenfeld, O. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00882-1 · Cited by 149
Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
Bargoni, A., Cavalli, R., Caputo, O., Fundaro', A., Gasco, M. R., & Zara, G. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011975120776 · Cited by 148
de Boer, A. H., Gjaltema, D., Hagedoorn, P., & Frijlink, H. W. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00526-4 · Cited by 147
Schöler, N., Olbrich, C., Tabatt, K., Müller, R. H., Hahn, H. H., & Liesenfeld, O. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00660-3 · Cited by 145
Clift, M. J. D., Gehr, P., & Rothen‐Rutishauser, B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0560-6 · Cited by 144
Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats
Bosquillon, C., Préat, V., & Vanbever, R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.027 · Cited by 140
Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect
Videira, M., Almeida, A. J., & Fabra, À. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.12.007 · Cited by 138
Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells
Choi, S. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.011 · Cited by 136
Dayan, A. D. (2000) · Occupational and Environmental Medicine · doi:10.1136/oem.57.6.431c · Cited by 132
Kaonga, F., Dezi, E., & Wiggin, T. (2003) · Tropical Doctor · doi:10.1177/004947550303300429 · Cited by 129
Thymopentin in solid lipid nanoparticles
Morel, S., Ugazio, E., Cavalli, R., & Gasco, M. R. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04388-8 · Cited by 123
No Significant Translocation of Inhaled 35-nm Carbon Particles to the Circulation in Humans
Wiebert, P., Sánchez-Crespo, A., Falk, R., Philipson, K., Lundin, A., Larsson, S., Möller, W., Kreyling, W. G., & Svartengren, M. (2006) · Inhalation Toxicology · doi:10.1080/08958370600748455 · Cited by 121
The stability of liposomes to nebulisation
Taylor, K. M. G., Taylor, G., Kellaway, I. W., et al. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90287-e · Cited by 119
Rudolph, C., Schillinger, U., Ortiz, A., Tabatt, K., Plank, C., Müller, R. H., & Rosenecker, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041463.56768.ec · Cited by 119
Receptors for Unopsonized Particles: The Role of Alveolar Macrophage Scavenger Receptors
Palecanda, A., & Kobzik, L. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363384 · Cited by 118
Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.
Dennis, J., Stenton, S., Beach, J. R., Avery, A. J., Walters, E. H., & Hendrick, D. J. (1990) · Thorax · doi:10.1136/thx.45.10.728 · Cited by 115
Heiati, H., TAWASHI, R., & Phillips, N. C. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006847 · Cited by 113
Morphological aspects of particle uptake by lung phagocytes
Geiser, M. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10105 · Cited by 111
Optimizing Aerosol Delivery by Pressurized Metered-Dose Inhalers
Rubin, B. K., & Fink, J. B. (2005) · Respiratory Care · doi:10.4187/respcare.05501191 · Cited by 103
Li, Y., Sun, X., Gong, T., Liu, J., Zuo, J., & Zhang, Z. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0201-z · Cited by 103
Low cytotoxicity of solid lipid nanoparticles inin vitroandex vivolung models
Nassimi, M., Schleh, C., Lauenstein, H.-D., Hussein, R., Lübbers, K., Pohlmann, G., Switalla, S., Sewald, K., Müller, M., Krug, N., et al. (2009) · Inhalation Toxicology · doi:10.1080/08958370903005769 · Cited by 98
Mechanisms, Measurement, and Significance of Lung Macrophage Function
Brain, J. D. (1992) · Environmental Health Perspectives · doi:10.1289/ehp.92975 · Cited by 88
Correlation between particle size, in vivo particle persistence, and lung injury.
Oberdörster, G., Ferin, J., & Lehnert, B. E. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.102-1567252 · Cited by 87
The migration of bronchoalveolar macrophages into hilar lymph nodes.
Corry, D. B., Kulkarni, P. V., & Lipscomb, M. F. (1984) · PubMed · Cited by 79
Elhissi, A. M. A., Hidayat, K., Phoenix, D. A., Mwesigwa, E., Crean, S., Ahmed, W., Faheem, A., & Taylor, K. M. G. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.12.040 · Cited by 70
Mollet, H., & Grubenmann, A. (1999) · Wiley eBooks · doi:10.1002/9783527625703.ch12 · Cited by 67
Inhalative nanomedicine—Opportunities and challenges
Bur, M., Henning, A., Hein, S., Schneider, M., & Lehr, C. (2009) · Inhalation Toxicology · doi:10.1080/08958370902962283 · Cited by 59
The nanoscale in pulmonary delivery. Part 2: formulation platforms
Rogueda, P., & Traini, D. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.6.607 · Cited by 58
(2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04825-5.x1000-8 · Cited by 57
New Methods for Lipid Nanoparticles Preparation
Corrias, F., & Lai, F. (2011) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221111797200597 · Cited by 56
Wiedmann, T. S., DeCastro, L., & Wood, R. W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012024021511 · Cited by 52
Lymphatic uptake of lipid nanoparticles following endotracheal administration
Videira, M., Gano, L., dos Santos, C. P., Neves, M., & Almeida, A. J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788221 · Cited by 49
Detection of Telomerase Expression in Mediastinal Lymph Nodes of Patients with Lung Cancer
Wallace, M. B., Block, M. I., Hoffman, B. J., Hawes, R. H., Silvestri, G. A., Reed, C. E., Mitas, M., Ravenel, J. G., Fraig, M., Miller, S., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200211-1297oc · Cited by 49
Timblin, C. R., Shukla, A., Berlanger, I., BéruBé, K., Churg, A., & Mossman, B. T. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9343 · Cited by 44
Olbrich, C., Schöler, N., Tabatt, K., et al. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023754 · Cited by 44
McIntire, G. L., Bacon, E. R., Toner, J. L., Cornacoff, J. B., Losco, P. E., Illig, K. J., Nikula, K. J., Muggenburg, B. A., & Ketai, L. H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980060r · Cited by 42
Beck‐Broichsitter, M., Schmehl, T., Seeger, W., & Gessler, T. (2010) · Journal of Nanomaterials · doi:10.1155/2011/163791 · Cited by 42
Schlesinger, R. B., Lung-Chi, C., & Driscoll, K. E. (1984) · Toxicology Letters · doi:10.1016/0378-4274(84)90074-2 · Cited by 32
Pulmonary alveolar pores and alveolar macrophage‐mediated particle clearance
Ferin, J. (1982) · The Anatomical Record · doi:10.1002/ar.1092030208 · Cited by 25
Supramicron-sized particle clearance from alveoli: route and kinetics
Langenback, E. G., Bergofsky, E. H., Halpern, J. G., & Foster, W. M. (1990) · Journal of Applied Physiology · doi:10.1152/jappl.1990.69.4.1302 · Cited by 25
Freitas, C., Lucks, J. S., & Müller, R. H. (1994) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(94)90411-1 · Cited by 18
Cytokine production in human and rat macrophages and dicatechol rooperol and esters
Guzdek, A., Niżankowska, E., ALLISON, A. C., et al. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00386-3 · Cited by 18
Effects of Cigarette Smoke and Air Pollutants on the Lower Respiratory Tract
Jeffery, P. K. (1999) · Air Pollution and Health · doi:10.1016/b978-012352335-8/50087-9 · Cited by 14
Defense Mechanisms of the Respiratory System
Schlesinger, R. B. (1982) · BioScience · doi:10.2307/1308754 · Cited by 13
Hanatani, K., Takada, K., Yoshida, N., Nakasuji, M., Morishita, Y., Yasako, K., Fujita, T., Yamamoto, A., & Muranishi, S. (1995) · Journal of drug targeting · doi:10.3109/10611869509015955 · Cited by 13
Cited by
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application
Naseri, N., Valizadeh, H., & Zakeri-Milani, P. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.043 · Cited by 1,116
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Essential oils: From extraction to encapsulation
Asbahani, A. E., Miladi, K., Badri, W., Sala, M., Addi, E. H. A., Casabianca, H., Mousadik, A. E., Hartmann, D., Jilale, A., Renaud, F. N. R., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.069 · Cited by 1,065
Mohammadi-Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 970
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Metadata
- Authors
- Weber, S., Zimmer, A., & Pardeike, J.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 86
- Issue
- 1
- Pages
- 7-22
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W1977143275
- Cited by
- 568
- References
- 140
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.